All prices include GST and are in NZ dollars
A changing treatment landscape? Current use of biologics in Rheumatology, Gastroenterology and Dermatology Programme - On Demand
Featured On Demand
Due to Popular demand, the Biologics Programme will be re-run in 2019.
Biologics, also known as biologic therapies or biologic response modifiers, have become an important part of modern healthcare. Join this programme to learn about the development of biologics, their efficacy, common adverse effects, monitoring, initiating these agents and more!
Dr Rebecca Grainger (Rheumatologist), Dr Stephen Inns (Gastroenterologist) and Dr Gerhard Eichhoff (Dermatologist) will each discuss in detail the use of biologics in their respective specialty field.
Remember this Programme can form part of your Group 3 goal on biologic therapies!
Adalimumab (Humira) in General Practice and Pharmacy - On Demand
In this course you will learn about the following topics:
- Defining Adalimumab
- How do patients benefit from Adalimumab
- Managing patients on Adalimumab
- Supportive care for patients on Adalimumab
- The importance of patient adherence – helping patients stay on track
Anaphylaxis - On Demand
All pharmacists have the potential to encounter anaphylaxis in their career. Complete this on demand learning to recognise anaphylaxis and its treatment. Learn about Pharmacist-led interventions in allergy management and education, and adjunctive treatments in allergy.
Clozapine Dispensing in Community Pharmacy On Demand Training Course
Clozapine has drastically improved the lives of many patients however it can cause many serious side effects. Clozapine is associated with a significant risk of neutropenia, which may progress to a potentially fatal agranulocytosis.
Common Musculoskeletal Disorders Basic Practice Update Workbook
The Common Musculoskeletal Disorders Best Practice Update Workbook has been expertly written by Dr Linda Bryant. This is an excellent and detailed workbook for any pharmacist wanting to update their knowledge.
Pre order your copy now for dispatch in late January 2017.